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Signaling NetworksÐ Minireview
Do All Roads Lead
to the Same Genes?
of a single Tyr at position 1257 of LET23 confers full
fertility but does not rescue viability or vulval induction.
Conversely the presence of any one of three Tyr sites
(1276, 1289, or 1311) with Grb2-binding motifs is suffi-
cient for viability and vulval differentiation, but not fertil-
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Department of Molecular and Medical Genetics ity. These and related data have indicated that the SH2-
binding sites of LET23 have distinct functions in vivo,University of Toronto
Toronto, Ontario M5S 1A8 possibly because they associate with tissue-specific ef-
fectors and negative regulators, but can also exhibit aCanada
degree of functional redundancy.
Multiple Pathways from Receptors to the Nucleus
There are several pathways through which pTyr signalsA significant issue in signal transduction is whether indi-
can be relayed to the nucleus (Figure 1). STAT proteinsvidual biochemical pathways activated in the cytoplasm
form dimers through mutual SH2-pTyr interactions andinduce unique, overlapping, or redundant alterations in
consequently translocate to the nucleus, where theythe pattern of expressed genes. In an article published
bind the promoters of cytokine-inducible genes. Thisin this issue of Cell, Fambrough et al. (1999) explore this
pathway is the most direct and potentially the mostquestion by using oligonucleotide arrays to assess RNA
selective route to the regulation of gene expression,transcripts induced by the b receptor for platelet-
since the SH2-containing target is the transcription fac-derived growth factor (bPDGFR) in mouse fibroblasts.
tor itself. Other signals wend a more tortuous path toFollowing activation by ligand binding, a receptor tyro-
the nucleus, providing more opportunity for cross-talksine kinase (RTK) such as the bPDGFR undergoes auto-
and branching through the actions of docking pro-phosphorylation at Tyr residues that bind cytoplasmic
teins, phospholipid kinases and phospholipases, smalltargets with phosphotyrosine (pTyr) recognition mod-
GTPases, and cascades of protein kinases that regulateules, notably SH2 domains (Pawson, 1995). These re-
MAP kinase family members such as Erk and JNK/SAPK.ceptor-binding proteins can be enzymes such as phos-
Such pathways can be described in linear terms. Thus,pholipase C (PLC)-g1, adaptor proteins that physically
binding of a Grb2-Sos complex to a receptor leads tolink the receptor to an enzyme, for example Grb2, which
activation of the Ras GTPase, which in turn stimulatesrecruits the Ras guanine nucleotide exchange factor
the Raf, Mek, and Erk protein kinases. Erk phosphory-Sos, latent transcription factors (STATs), scaffolding
lates ternary complex factors (TCFs), which associateproteins like Shc, or negative regulators such as Cbl.
with serum response factor (SRF) and initiate tran-Since each SH2-containing protein binds preferentially
scription through the serum response element of genesto a distinct phosphorylated motif, it is possible to engi-
such as c-fos (Price et al., 1995). Phosphatidylinositolneer mutant receptors in which specific Tyr docking
39-kinase (PI3K) is activated by direct binding of its SH2-residues are replaced by Phe, thereby selectively uncou-
containing subunit to receptors and catalyzes the forma-pling the receptor from a particular pathway. In this
tion of PI-3,4,5-P3, which engages the PH domains ofway, the importance of a signaling pathway for a given
downstream targets such as the serine/threonine-spe-biological response can be evaluated, either in vivo or
cific protein kinases PKB/AKT and PDK1. PKB, oncein cultured cells.
activated, can potentially regulate multiple transcriptionExperiments of this sort have shown that docking
factors, including c-Jun, and members of the Forkheadsites for SH2 proteins confer an element of biological
family such as FKHRL1 and AFX that are retained inspecificity. Met, the receptor for hepatocyte growth fac-
the cytoplasm upon phosphorylation by PKB (Brunet ettor, has two C-terminal autophosphorylation sites that
al., 1999; Kops et al., 1999). PI3K can also stimulate theengage multiple SH2 proteins. Substitution of these two
Rac GTPase, which has been implicated in JNK/SAPKTyr residues in the mouse gives the same embryonic
activation and thereby in the positive phosphorylationlethal phenotype as a null Met mutation. In contrast,
of c-Jun and ATF2. In addition, the SH2 domain proteinmice with a substitution that only blocks Grb2-binding
PLC-g1, by hydrolyzing PI-4,5-P2 to IP3 and diacylglyc-to Met survive to birth, but show a selective defect in
erol, can potentially influence calcium-sensitive tran-development of the limb musculature (Maina et al.,
scription factors such as NFAT isoforms and stimulate1996). Similarly, mutation of the PLC-g1 binding site on
protein kinase C (PKC) signaling. Even this greatly sim-the fibroblast growth factor (FGF) receptor 1 results in
plified picture reveals several distinct means throughaltered Hox gene expression and homeotic transforma-
which RTK signaling may either increase or repress tran-tions in the mouse (Partanen et al., 1998). A detailed
scription.analysis has been made for LET23, the epidermal growth
However, cytoplasmic signaling proteins are increas-factor (EGF) receptor homolog in Caenorhabditis ele-
ingly seen to form networks of interactions rather thangans, which has six potential SH2-binding sites that
simple linear pathways (Pawson, 1995). This may becontribute to signaling (Lesa and Sternberg, 1997).
observed at almost every step of the signaling process.Worms expressing a mutant receptor lacking all six of
The bPDGFR, for example, can bind the Grb2 SH2 do-these Tyr residues are severely impaired for viability,
formation of the vulva, and fertility. However, restoration main either directly or indirectly through Shc or Shp2
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Figure 1. A Signaling Network from the Acti-
vated bPDGFR
The activated receptor is a dimer. Each re-
ceptor chain becomes phosphorylated on
multiple sites, some of which are depicted
here, and binds specific SH2-containing pro-
teins. The receptor itself has redundant inter-
actions, for example with Grb2. There are
specific pathways leading from the receptor
to the nucleus, each outlined in a different
color. There are also numerous potential
cross-connections between distinct path-
ways, some of which are shown. See the text
for more detail. The figure is illustrative and
by no means comprehensive; some binding
partners and potential pathways, including
Src family kinases, are not depicted.
(Heldin et al., 1998). There are also numerous cross- reference sources. The data therefore represent relative
RNA message abundance based on a direct comparisonconnections between signaling proteins more distal to
of these two transcriptional states. This method givesthe receptor. Ras can bind PI3K and potentiate its acti-
the ability to globally assess gene expression and tovation (Rodriguez-Viciana et al., 1994), while the Rac-
identify sets of transcripts that respond in a similar fash-dependent protein kinase PAK can phosphorylate Mek
ion to a given stimulus or physiological state, and mayand thereby stabilize its association with Raf (Frost et
therefore have a related function. Such experiments canal., 1997). PLC-g1 has a PIP3-sensitive PH domain (Fa-
yield unanticipated results, as shown by Iyer and col-lasca et al., 1998), and in some cells PKC can enhance
leagues who examined genes induced or repressed atthe activation of Raf by Ras.GTP (Marais et al., 1998).
various times after serum stimulation of primary fibro-As a consequence, the activation of distinct signaling
blasts using cDNA arrays (Iyer et al., 1999). Cluster analy-pathways at the membrane may potentially converge
sis revealed the induction or repression of known IEGs,on a related set of promoters.
as well as genes for signaling proteins and cell cycleGeneric or Specific Transcriptional Responses
regulators. However, a large number of the inducedto Receptor Signaling?
genes proved to be involved in the physiology of woundTo explore the ability of different signaling pathways to
repair, which in hindsight makes sense for a fibroblastmodify gene expression, Fambrough et al. have selected
exposed to serum.a specific model system, namely the activation of imme-
In NIH 3T3 cells expressing the chimeric M-CSF/diate early genes (IEGs) by the bPGDFR in NIH 3T3 cells.
bPDGFR and stimulated with saturating amounts ofIEGs represent direct nuclear targets of cytoplasmic
M-CSF for up to 4 hr, Fambrough et al. initially classifiedsignaling pathways, since their transcriptional response
66 genes as IEGs based on an induction of approxi-does not require novel protein synthesis. To circumvent
mately 3-fold by ligand. Reassuringly about half of theseendogenous bPDGFR, the authors have fused the extra-
genes had previously been identified as IEGs. The ques-cellular region of the macrophage colony±stimulating
tion then is whether individual signaling pathways elicitfactor (M-CSF) receptor to a cytoplasmic region con-
unique subsets of IEGs, or stimulate a broad range oftaining either wild-type or mutant bPDGFR sequences.
IEG expression. The answer seems to be that in NIH
In mutant versions of this chimeric receptor, up to six Tyr
3T3 cells distinct pathways can have surprisingly similar
residues that bind SH2-signaling proteins are altered, in
transcriptional outputs, but that some genes respond
combination, to Phe. The bPDGFR is remarkably well to specific signals. Of the 66 IEGs, 64 were induced by
endowed with binding sites for SH2 proteins, including the 5F mutant receptor, which lacks the principal binding
PLC-g1, PI3K, Shp2, RasGAP (a negative regulator of sites for PLC-g1, Shp2, RasGAP and PI3K, to about half
the Ras GTPase), Src family tyrosine kinases, STAT5, the level shown by the wild-type receptor; only KC and
and adaptors such as Grb2, Shc, Grb7, and Nck (Heldin chop-10 did not respond to M-CSF. Ablation of an addi-
et al., 1998; RoÈ nnstrand et al., 1999). Mutants receptors tional SH2-docking site implicated in Grb2 binding in
with Tyr→Phe substitutions at five sites (5F; Tyr 740, the 6F mutant caused a further reduction averaging 1.5-
751, 771, 1009, and 1021), with an additional substitution fold among 37 genes analyzed, but did not entirely elimi-
at Tyr 716 (6F), or with single Tyr residues restored to nate IEG induction by ligand. The residual signaling of
the 5F mutant, were tested for their ability to induce IEG this 6F mutant may potentially be explained by the fact
expression in NIH 3T3 cells. The novelty of the current that even this somewhat threadbare receptor retains
work involves the use of oligonucleotide arrays to coor- several pTyr/SH2-binding sites (Heldin et al., 1998). In
dinately assess the response of 5,938 genes, represent- addition, the kinase domain of the bPDGFR alone may
ing between 5% and 10% of the total mouse genome. transmit a signal by phosphorylating SH2-docking pro-
DNA microarrays are a powerful tool for the compre- teins, as shown for a truncated EGF receptor that retains
hensive analysis of variations in RNA expression pat- the ability to phosphorylate Shc and transform cells
terns (Brown and Botstein, 1999). In the approach em- (Soler et al., 1994).
ployed by Fambrough et al., high density oligonucleotide In general terms, these results suggest that the dis-
tinct biochemical pathways activated by the receptorarrays are probed with labeled cRNA pools from test or
Minireview
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can ultimately have related outputs at the level of IEG newly activated transcription factors, which target dif-
expression, and that each pathway has a quantitative ferent promoters. The same signal may therefore induce
rather than qualitative effect on transcriptional regula- distinct transcriptional readouts in different cells. It is
tion. This is consistent with previous work from the Kaz- also possible that within any one cell the same signal,
lauskas laboratory suggesting functional redundancy in or group of signals, may have different effects de-
mitogenic signaling by the bPDGFR, at least through pending on the strength with which it is delivered. This
the PI3K and PLC-g1 pathways (Valius and Kazlauskas, may apply for signaling through the T cell antigen recep-
1993). The authors also show that FGF and PDGF induce tor (TCR). The nonpolymorphic signaling subunits of the
a similar IEG response in NIH 3T3 cells, again suggesting TCR (the z and CD3 chains) contain an aggregate of 12
that distinct signals can elicit a rather generic transcrip- closely related tyrosine phosphorylation sites that act
tional output. However, the data also provide evidence in pairs to engage the tandem SH2 domains of the ZAP-
for specificity. A 5F mutant receptor to which the Tyr- 70 tyrosine kinase (Kersh et al., 1998). When an MHC/
1021 PLC-g1 binding site had been restored induced the antigen complex engages the TCR, it induces a signal
expression of KC and chop-10, suggesting that these that can have markedly different outcomes on T cell
genes may be relatively specific targets of PLC-g1 sig- development. For example, a cell with a TCR that binds
naling. More strikingly, a 5F mutant with a restored Tyr- with high affinity to self-antigen will be negatively se-
771 binding site for RasGAP induced a novel series of lected, while cells with TCRs that bind antigen with mod-
genes that are normally activated by interferon-g, which erate affinity will proliferate and undergo further devel-
signals through the STAT1 transcription factor. It is pos- opment. Thus, quantitative differences in TCR signaling
sible that recruitment of RasGAP to an impaired receptor can potentially translate into qualitatively distinct biolog-
unmasks STAT1 activity by attenuating a Ras signal that ical reponses.
otherwise leads to inhibitory phosphorylation of STAT1 A possible advantage of a signaling network with mul-
on serine. While the physiological relevance of this find- tiple intersecting pathways is to direct a coherent re-
ing in the context of the bPDGFR is uncertain, it makes sponse to numerous, potentially conflicting signals. In
the point that an individual pTyr-initiated signal can in- vivo a single cell will be exposed to multiple stimuli in
duce a specific, as opposed to a global, transcriptional the form of soluble hormones, cell surface proteins on
response. adjacent cells, and extracellular matrix components.
There are several caveats to these experiments, as These different signals may act synergistically to en-
the authors themselves point out. One reservation is hance an internal pathway, as shown for growth factors
that the experiments were all performed at saturating and fibronectin in MAP kinase signaling, or may antago-
concentrations of ligand, which is unlikely to be physio- nize one another as found for interferon-g, which inhibits
logical and may emphasize the propensity of signaling TGFb signaling by inducing expression of the inhibitory
pathways to cross-activate. For example, PI3K is acti- Smad7 (Ulloa et al., 1999). With the focus here on IEG
vated by Ras only at higher concentrations of growth expression, it is also important to consider that path-
factor. Thus, it will be important to know whether spe- ways leading to transcriptional regulation are also es-
cific biochemical pathways induce distinct subsets of sential for other cellular responses (Heldin et al., 1998).
IEGs when cells are stimulated with lower concentra- As an example, PI3K regulation also plays an essential
tions of ligand. Sensibly, the authors have simplified a role in reorganization of the actin cytoskeleton and di-
complex task by focusing on IEGs that show signifi- rected migration in response to PDGF. Furthermore, by
cantly elevated expression. Obviously this does not take controling signaling to p70 S6 kinase and 4EBP proteins,
into account transcriptional repression, nor subsequent which together regulate protein synthesis, the PI3K
waves of gene induction. Further, although the authors pathway organizes cell growth. Through PKB, PI3K can
have sampled a prodigious number of genes, it will be also induce phosphorylation of the proapoptotic protein
important to know what fraction of the remaining 90%±
Bad in some cells, and thereby enhance survival. Thus,
95% of promoters show pathway-specific responses.
the same network of signaling proteins downstream of
Another issue is the degree to which the data obtained
receptors must coordinate numerous cellular functions.for NIH 3T3 cells, which are highly adapted to life on
Perhaps for this reason, eukaryotic cells have evolvedplastic, can be generalized to other cells. Even more
scaffolding proteins that can simultaneously bind multi-important will be to determine the roles of distinct signal-
ple components of a signaling pathway and therebying pathways activated by the bPDGFR (and the related
impose a degree of specificity and order on the highlyaPDGF receptor) in vivo, by introducing the relevant
interactive network of signaling proteins.Tyr→Phe mutations into the mouse germline, allowing
Subtle Differences in Gene Expression Can Havethe investigation of the nuances of gene expression in
Important Biological Consequencesmice with such mutant receptors.
The virtues of signaling networks aside, minor differ-Signaling Proteins Are Organized into Networks
ences in gene expression can potentially result in dra-These cautions aside, the current data fit an emerging
matically different developmental programs. To illus-notion that a limited number of signaling proteins inter-
trate, the expression of single ªselector genes,º suchact in a combinatorial fashion to build intracellular net-
as Ubx or Tbx5, distinguishes whether a wing or haltereworks that allow diverse cellular responses. Thus, it is
will develop from a Drosophila imaginal disc or whethercritical to understand how biological specificity can be
a forelimb or hindlimb will outgrow from the chick bodygenerated through rather general intracellular signals.
wall (Weatherbee and Carroll, 1999). Elegant examplesCells with different histories, and therefore expressing
from Drosophila show that subtle differences in genedifferent repertoires of transcription factors and coacti-
vators, may form distinct complexes of preexisting and expression induced by a RTK can influence biological
Cell
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Partanen, J., Schwartz, L., and Rossant, J. (1998). Genes Dev. 12,output. The Torso receptor signals through the Drosoph-
2332±2344.ila Grb2 ortholog and the Ras pathway to induce the
Pawson, T. (1995). Nature 373, 573±580.expression of tailless (tll) and huckebein (hkb), which
Price, M.A., Rogers, A.E., and Treisman, R. (1995). EMBO J. 14,specify terminal cell fate. The recruitment of Csw (the
2589±2601.ortholog of the tyrosine phosphatase Shp2) to Torso
Rodriguez-Viciana, P., Warne, P.H., Dhand, R., Vanhaesbroek, B.,mediates the transmission of receptor signals, as dem-
Gout, I., Fry, M.J., Waterfield, M.D., and Downward, J. (1994). Natureonstrated by a Tyr→Phe substitution in Torso, which
370, 527±532.
blocks this association and yields a loss-of-function
RoÈ nnstrand, L., Arvidsson, A.-K., Kallin, A., Rorsman, C., Hellman,phenotype. In contrast, mutation of the Torso-binding
U., EngstroÈ m, U., Wernstedt, C., and Heldin, C.-H. (1999). Oncogene,
site for RasGAP gives a gain-of-function phenotype, as in press.
might be expected if RasGAP inhibits Ras signaling. Soler, C., Alvarez, C.V., Beguinot, L., and Carpenter, G. (1994). Onco-
An important effect of these competing regulators is gene 9, 2207±2215.
to define the spatial boundaries of tll/hkb expression. Ulloa, L., Doody, J., and Massague, J. (1999). Nature 397, 710±713.
Interestingly, substitution of the RasGAP-binding site Valius, M., and Kazlauskas, A. (1993). Cell 73, 321±334.
restores signaling to a Torso mutant that cannot bind Weatherbee, S.D., and Carroll, S.B. (1999). Cell 97, 283±286.
Csw, apparently because a major substrate for the Csw
phosphatase is the pTyr motif that recruits RasGAP
(Cleghon et al., 1998). However, these compensatory
signals are still required for proper refinement of the
Torso signal, as survival to adulthood is markedly re-
duced in flies expressing a Torso mutant lacking both
Csw and RasGAP-binding sites.
Oligonucleotide and cDNA arrays are clearly changing
the ways we think about cell biology. The paper by
Fambrough et al. reveals both the power of this ap-
proach, and also our ignorance about cellular function.
It will be fascinating in the future to extend the gene
chip technology to a more comprehensive analysis of
growth factor signaling. This approach may also be use-
ful in resolving the role of other PDGFR binding partners,
such as Src family kinases, in regulating the transcrip-
tional response to PDGF. It may be particularly revealing
to use inhibitors to proteins more proximal to the IEG
promoters, such as components of the MAP kinase cas-
settes, to tease out whether there is increased specific-
ity as one gets further down the signaling pathways.
Regardless, Pandora's box has now been opened.
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